David Bench is CFO at ENZO BIOCHEM INC (ENZ). They have made 1 open-market trade across 1 company since 2022, most recently 2022-06-14.
CIK 0001797876
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENZ | 6,000 | $2K |
Shares reported on the most recent Form 4, priced at the 2022-06-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENZ | BUY | 2022-06-14 | 2022-06-15 | $2.15 | $8K | -9.1% | +9.1% | +1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.